Ottawa companies receive FedDev funding for AI, semiconductor, biotech work
FedDev invested nearly $20 million across nine Ottawa-based companies.
FedDev invested nearly $20 million across nine Ottawa-based companies.
VoxCell’s 3D bioprinted imitation of natural soft tissue helps pharmaceutical companies test new drugs faster.
Plus: Telehealth execs charged with fraud.
The deals, if successful, will have a combined value of over $36 million.
Each startup is receiving between $150,000 to $500,000 based on company stage, needs, and evaluation processes.
Heylist, Vosyn, Pok Pok, and Ability Biologics have all raised fresh capital.
Plus: Feds table bill with new healthtech data security rules.
The financing follows Kardium’s $158-million CAD round in 2021.
Plus: The new Alberta program looking to connect the healthtech ecosystem.
GreenSky-backed University of Toronto spinout has set its initial sights on dentistry.
Valsoft closed $229 million CAD in growth financing in January to expand its portfolio.
Biotech startup aims to unlock hair regrowth, skin rejuvenation, disease treatment by preserving cells.
After finding product-market fit, Ginger Desk aims to build the platform it needs to scale.
Plus: Once worth $2.3B, COVID-19 test maker Cue Health shutters.
IDEATE is being supported by a $2.1-million investment from PrairiesCan.